Dementia-Shingles Vax Study; ALS Cluster Spotted; Why Dementia Tsunami May Subside

Since December, there has been a run on the shingles vaccine. Problem: it is expensive and not reimbursed. Why are the elderly so worried and why is the vaccine so expensive?

Dementia-Shingles Vax Study; ALS Cluster Spotted; Why Dementia Tsunami May Subside

(MedPage Today) -- GSK is partnering with the U.K. Dementia Research Institute and Health Data Research U.K. to explore possible links between the company's shingles vaccine and a reduced risk of dementia. A cluster of 16 people were diagnosed...

Pharmalittle: We're reading about NIH removing scientific advisers, GSK's shingles shot, and more

Rise and shine, everyone, another busy day is on the way. We can tell by the parade of motor vehicles passing by the Pharmalot campus and the continuous rumble of commuter trains off in the distance. As for us, we are engaged in the usual ritual of brewing cups of stimulation. Our choice today is coconut rum, a delicious household favorite. As always, you are invited to join us. After all, the neurons could use all the help they can get, would y…

GSK taps into UK health data for dementia study

GSK joins with two UK research organisations to explore a possible link between its shingles vaccine Shingrix and a reduced risk of dementia

GSK Studying If Blockbuster Shingles Shot Reduces Dementia Risk

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the shot.

GSK Launches First-of-Its-Kind Study on Shingles Vaccine and Dementia Risk in the UK

GSK announced a research collaboration with the UK DRI and HDR UK to study neurodegeneration through a novel dementia study.